Cellesce Ltd
Company Details
Status: Private
Employees: 1-10
Location:
Cardiff Medicentre, Heath Park, Cardiff CF14 4UJ, Cardiff, Cardiff CF14 4UJ, GB
Type:
sample
sample
sample
sample
sample
sample
Technology:
sample
sample
About: Cellesce Ltd is a biotechnology company based in Cardiff, Wales, that focuses on organoid research and bioprocessing technologies. Established in 2013, the company specializes in patient-derived organoids (PDOs) for cancer research, utilizing patented bioprocessing technology to standardize and scale organoid production.
The company offers several core services, including the development and manufacturing of standardized cancer organoids for large-scale applications such as compound screening and high-throughput drug discovery. Cellesce also provides scale-up solutions to ensure reproducible organoid batches, meeting the needs of pharmaceutical testing. Additionally, it supports drug discovery pipelines with customized organoid models, particularly in oncology.
In December 2022, Cellesce was acquired by Molecular Devices, enhancing its capabilities in integrating organoid technology into drug discovery platforms. The company reported $7.8 million in annual revenue for 2024 and operates with a small team, emphasizing its commitment to advancing organoid-based precision medicine.
Unlock access to company contacts, hot leads, and drug pipelines.
Log in or create a free account now!
Cellesce Ltd | Active clinical trials on ClinicalTrials.gov
Active Clinical Trials Count | 0
No Active Trials Found On ClinicalTrials.gov.